SEC Form D · Amendment · filed September 11, 2023
GLO Pharma, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Vimla Black-Gupta · Carlsbad, CAExec · DirectorNicole Quinn · Carlsbad, CADirectorDayna Quanbeck · Carlsbad, CADirectorLauren Otsuki · Carlsbad, CAExec · DirectorMarla Beck · Carlsbad, CADirectorFabian Seelbach · Carlsbad, CADirectorDouglas Wall · SAN DIEGO, CADirectorJeff Stinson · Little Rock, ARDirectorVincent P. Corso Iii · New Orleans, LAExec · DirectorDerive Ventures GP I, LLC · SAN FRANCISCO, CAExec · DirectorDayna Quanbeck · Carlsbad, CADirectorEnzo A. D'Angelo · Chicago, ILDirectorMaureen Case · Carlsbad, CADirectorJacob B. Jones · Raleigh, NCDirectorGordon V. Tucker · Raleigh, NCExec · DirectorSriram Krishnan · Palo Alto, CADirectorAsiff Hirji · Miami, FLDirectorMaximilian Crown · Miami, FLExec · DirectorMaureen Case · Carlsbad, CADirectorFabian Seelbach · Carlsbad, CADirectorDouglas Wall · VISTA, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗